Clinical trial • Phase I • Oncology
Clinical trial in Advanced malignant solid tumors
Phase I trial for Advanced malignant solid tumors. 44 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced malignant solid tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 19-01-2026
- First CTIS Authorization Date
- 24-03-2026
Trial design
Phase I trial in Spain.
- Target Sample Size
- 44
Eligibility
Recruits 44 Vulnerable population selected (isVulnerablePopulationSelected = true); no further details on consent or assent handling provided in the record..
- Vulnerable Population
- Vulnerable population selected (isVulnerablePopulationSelected = true); no further details on consent or assent handling provided in the record.
Recruitment
- Planned Sample Size
- 44
- Recruitment Window Months
- 56
- Consent Approach
- Not specified in the provided record.
Geography
- Total Number Of Sites
- 10
- Total Number Of Participants
- 77
Spain
- Earliest CTIS Part Ii Submission Date
- 19-02-2026
- Latest Decision Or Authorization Date
- 24-03-2026
- Processing Time Days
- 33
- Number Of Sites
- 10
- Number Of Participants
- 77
Sites
- Site Name
- Hospital Quironsalud Barcelona
- Department Name
- Oncology
- Contact Person Name
- Fabricio Racca Bussano
- Contact Person Email
- fracca@nextoncology.eu
- Site Name
- Clara Campal Comprehensive Cancer Center
- Department Name
- Oncology
- Contact Person Name
- Juan Jose Soto
- Contact Person Email
- juanj.soto@startmadrid.com
- Site Name
- Clinica Universidad De Navarra
- Department Name
- Oncology
- Contact Person Name
- Ignacio Melero Bermejo
- Contact Person Email
- imelero@unav.es
- Site Name
- Hospital San Pedro
- Department Name
- Oncology
- Contact Person Name
- Maria Jose De Miguel Luken
- Contact Person Email
- maria.demiguel@startrioja.com
- Site Name
- Clinica Universidad De Navarra (Madrid site)
- Department Name
- Oncology
- Contact Person Name
- Ignacio Melero Bermejo
- Contact Person Email
- imelero@unav.es
- Site Name
- Hospital Universitario 12 De Octubre
- Department Name
- Oncology
- Contact Person Name
- Santiago Ponce Aix
- Contact Person Email
- santiago.ponce@oncosur.org
- Site Name
- Hospital Hm Nou Delfos
- Department Name
- Oncology
- Contact Person Name
- Tatiana Hernandez Guerrero
- Contact Person Email
- tatiana.hernandez@start-barcelona.com
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Oncology
- Contact Person Name
- Elena Garralda Cabañas
- Contact Person Email
- egarralda@vhio.net
- Site Name
- Hospital Universitario Quironsalud Madrid
- Department Name
- Oncology
- Contact Person Name
- Valentina Boni
- Contact Person Email
- vboni@nextoncology.eu
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Oncology
- Contact Person Name
- Manuel Pedregal Trujillo
- Contact Person Email
- manuel.pedregal@startmadrid.com
Sponsor
Primary sponsor
- Full Name
- Genmab A/S
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Denmark
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)